Polypharmacy and Potential Drug Interactions Causing Neurological Symptoms in Geriatric Patients with Epilepsy

Polypharmacy and Potential Drug Interactions Causing Neurological Symptoms in Geriatric Patients with Epilepsy

Objective:Polypharmacy brings with it the risk of potential drug interaction. This study aimed to investigate polypharmacy, potential drug interactions, the drug interactions causing neurological symptoms in geriatric patients with epilepsy, and diffenrences between drug interaction databases.Method...

Full description

Bibliographic Details
Main Author:	Bahar Erbaş
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2022-09-01
Series:	Archives of Epilepsy
Subjects:	drug interactions epilepsy polypharmacy
Online Access:	http://archepilepsy.org/archives/archive-detail/article-preview/polypharmacy-and-potential-drug-nteractions-causin/54573

Similar Items

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
by: Ivan Krečak, et al.
Published: (2023-04-01)

Polypharmacy and potential drug–drug interactions in patients with rheumatoid arthritis
by: Zakaria M Al-Ghazaly, et al.
Published: (2022-01-01)

Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
by: Adetola Olaniyi Bojuwoye, et al.
Published: (2022-12-01)

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College
by: Akshay Khandeparkar, et al.
Published: (2017-01-01)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
by: Bianca Papotti, et al.
Published: (2021-01-01)

Frequency of polypharmacy and drug interactions in inpatients in the emergency department, Southwest of Iran
by: Mobina Tahmasebivand, et al.
Published: (2021-03-01)

Evaluation of Polypharmacy and Drug Interactions in the Treatment of Patients with Sepsis
by: Nursel Sürmelioğlu, et al.
Published: (2021-09-01)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
by: Marwan Sheikh-Taha, et al.
Published: (2021-04-01)

Rationale, design, and methodology of the EPIC (Epidemiology of Polypharmacy and Potential Drug-Drug Interactions in Elderly Cardiac Outpatients) study
by: Eda Özlek, et al.
Published: (2019-07-01)

Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study
by: Reham M. Alhumaidi, et al.
Published: (2023-06-01)

Drug utilization pattern and factors associated with polypharmacy and excessive polypharmacy in geriatric medical out-patients at a rural health training centre in India
by: S Nitya, et al.
Published: (2021-01-01)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
by: Hermann M, et al.
Published: (2021-03-01)

Polypharmacy: An Overview
by: Nelisa Paidamwoyo Ganga
Published: (2022-12-01)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
by: Dario Cattaneo, et al.
Published: (2023-07-01)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
by: Assefa YA, et al.
Published: (2020-01-01)

Interactions between prescription drugs in hospitalized geriatric patients
by: Erika Palacios-Rosas, et al.
Published: (2021-07-01)

Polypharmacy in Older Adults with Alzheimer’s Disease
by: Satoru Esumi, et al.
Published: (2022-10-01)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
by: Paula Bachmann, et al.
Published: (2022-03-01)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic
by: Dario Cattaneo, et al.
Published: (2024-01-01)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
by: Juveriya Farooq, et al.
Published: (2023-08-01)

Survey of polypharmacy prescription in a tertiary care Hospital, Belagavi
by: Suma Sukumaran, et al.
Published: (2021-11-01)

Polypharmacy in Older Adults (Out of Print)
by: Eric Orton
Published: (2007-01-01)

Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential
by: Mauro Cataldi, et al.
Published: (2023-08-01)

Nurses Opinion on the Attributes of Polypharmacy in Patient Safety
by: John Lisha Jenny, et al.
Published: (2012-07-01)

Nurses Opinion on the Attributes of Polypharmacy in Patient Safety
by: Fathi Mohamed Mohamed, et al.
Published: (2012-07-01)

Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia
by: Adem L, et al.
Published: (2022-04-01)

Opioids, Polypharmacy, and Drug Interactions: A Technological Paradigm Shift Is Needed to Ameliorate the Ongoing Opioid Epidemic
by: Adriana Matos, et al.
Published: (2020-08-01)

Polypharmacy in the elderly
by: Negar Golchin, et al.
Published: (2015-01-01)

Polypharmacy May Be the Cause of Acute Lithium Intoxication at the Second Day of Treatment
by: Tursun Irfan, et al.
Published: (2015-12-01)

Polypharmacy among older adults in Tehran
by: B. Ahmadi, et al.
Published: (2006-08-01)

Polypharmacy in Osteoporosis Patients
by: Yavuz Ali Karahan, et al.
Published: (2015-04-01)

Assessment of Potential Drug-drug Interactions among Ischaemic Stroke Patients in a Charitable Hospital
by: Amala Johnson, et al.
Published: (2022-07-01)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020-09-01)

Polypharmacy and potential inappropriate drug use in the elderly admitted to the general internal medicine outpatient clinic
by: Celaleddin Demircan, et al.
Published: (2021-03-01)

Polypharmacy among adults aged over 65 years
by: Patrycja Misztal-Okońska, et al.
Published: (2017-08-01)

Individual Pharmacotherapy Management (IPM)—IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy
by: Ursula Wolf, et al.
Published: (2022-10-01)

Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
by: Tommaso Sciarra, et al.
Published: (2019-09-01)

Polypharmacy, potentially serious clinically relevant drug‐drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life
by: Labib AL‐Musawe, et al.
Published: (2020-08-01)

The evolution of polypharmacy: appropriate and problematic polypharmacy, choosing the right strategy and tactics
by: M. V. Leonova
Published: (2021-10-01)

Pharmacotherapy in a Multidisciplinary Paediatric Hospital: Polypharmacy and Drug–Drug Interaction Risk Illustrated with a Clinical Case
by: M. N. Kostyleva, et al.
Published: (2022-10-01)